Related Experiment Video
Updated: Jun 18, 2025

05:34
Sexual Crosses with the Mucoromycete Phycomyces blakesleeanus
Published on: June 6, 2025
62
Mucormycosis: A sweet enemy, case series
Santiago Manrique-Castaño1, Luis Armando Velásquez-Trujillo1, Mariana Ángel Correa2
1Departamento de Medicina Interna, Escuela de Medicina, Facultad de Salud, Universidad del Valle, Cali, Colombia.
Biomedica : Revista Del Instituto Nacional De Salud
|August 1, 2024
Summary
Rhinocerebral mucormycosis, a rare fungal infection, affects immunocompromised individuals, particularly those with uncontrolled type 2 diabetes mellitus. Early diagnosis and treatment with liposomal amphotericin B and surgery are crucial for better outcomes.
Area of Science:
- Mycology
- Infectious Diseases
- Ophthalmology
Background:
- Mucormycosis is a rare, life-threatening fungal infection caused by Mucorales fungi.
- It primarily affects immunocompromised individuals or those with compromised skin/mucosal barriers.
- Rhinocerebral mucormycosis is a severe form affecting the sinuses and brain.
Purpose of the Study:
- To report four cases of rhinocerebral mucormycosis in Cali, Colombia.
- To highlight the association with type 2 diabetes mellitus and poor glycemic control.
- To discuss diagnosis, treatment, and outcomes of this rare infection.
Main Methods:
- Case series of four patients with rhinocerebral mucormycosis over three years.
- Diagnosis confirmed by direct visualization of fungal hyphae in biopsies.
- Assessment of patient history, comorbidities (especially diabetes), and treatment response.
Main Results:
- All four patients had type 2 diabetes mellitus with high glycated hemoglobin (>10%).
- Treatment involved liposomal amphotericin B and surgical debridement.
- Outcomes varied: one patient died, one left treatment, and two showed adequate recovery.
Conclusions:
- Uncontrolled diabetes is a significant risk factor for rhinocerebral mucormycosis.
- Prompt diagnosis and aggressive treatment (antifungal therapy and surgery) are vital.
- Effective management requires addressing underlying conditions and potential coinfections.

